XEN 45 GTS
Report
- Report Number
- 3011299751-2021-00165
- Event Type
- Injury
- Date Received
- May 14, 2021
- Date of Event
- February 28, 2021
- Report Date
- May 14, 2021
- Manufacturer
- ALLERGAN (IRVINE)
- Product Code
- KYF
- PMA / PMN Number
- K161457
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
Narratives
ARTICLE CITATION: ASANAD S., KALARN S., KALEEM, M. "POSTOPERATIVE COMPLICATIONS OF AB-INTERNO XEN IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA." AM J CLIN EXP IMMUNOL, VOL. 10, NO. 1, 2021, 44-47. WWW.AJCEI.US. ISSN: 2164-7712. FACILITY NAME: MEDICINE. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENTS OF GEL STENT BLOCKAGE AND DEVICE MIGRATION ARE ADDRESSED IN THE PRODUCT LABELING.
REPORTED EVENTS OF "BY SIX WEEKS POST-IMPLANT, SLIT LAMP BIOMICROSCOPY REVEALED OBSTRUCTION OF THE STENT LUMEN BY THE IRIS ALONG WITH IRIS PIGMENT DEPOSITS TRAVERSING TO THE DISTAL CONJUNCTIVAL END OF THE STENT WITHIN THE BLEB. THE INTRAOCULAR PRESSURE (IOP) HAD INCREASED TO 24 MMHG. STENT WAS NOTED TO BE DISLOCATED AND CURLED AGAINST THE IRIS WITHOUT CORNEAL TOUCH. RESTARTED ON GLAUCOMA MEDICATIONS AND SCHEDULED FOR REVISION SURGERY. DURING REPOSITIONING VIA AB-EXTERNO APPROACH, STENT WAS DECAPITATED. STENT THEN REMOVED AND IOP LOWERED TO 10 MMHG. IOP REMAINS STABLE WITHOUT GLAUCOMA MEDICATIONS AND RESIDUAL IRIS ATROPHY" WERE NOTED IN THE ARTICLE: "POSTOPERATIVE COMPLICATIONS OF AB-INTERNO XEN IMPLANTATION IN PRIMARY ANGLE CLOSURE GLAUCOMA." AM J CLIN EXP IMMUNOL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 720887 | XEN 45 GTS | IMPLANT, EYE VALVE | KYF | ALLERGAN (IRVINE) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 86 YR | Required Intervention |